Shares of Aehr Test Systems (AEHR) are having a very good Thursday morning. The stock jumped nearly 15% in premarket trading after the company announced it just landed a record $41 million production order from a lead hyperscale AI customer. That’s the kind of news that gets investors excited, especially when the broader market is only inching higher.

So, what’s the big deal? It’s not just the size of the check—though $41 million is nothing to sneeze at—it’s what it represents. This order is for a large batch of Aehr’s Sonoma systems, which are used for high-power package-level testing and burn-in of semiconductors, plus all the consumables needed to get them running. Think of it as the company getting a massive vote of confidence for its role in the AI processor supply chain. Deliveries are scheduled to start in Aehr’s fiscal 2027, which begins on June 27, 2026. It’s a clear signal that demand for these specialized testing solutions in the AI sector isn’t just strong; it’s getting stronger.

Bookings Are Blowing Past Expectations

Here’s where it gets even more interesting. This $41 million win isn’t an isolated event; it’s part of a much bigger trend for Aehr. "With this order, Aehr has now booked over $92 million in orders in the second half of this fiscal year, already exceeding our recently increased expectations, which we provided last week, for bookings on the high side of $60 million to $80 million during this period," said Gayn Erickson, President and CEO of Aehr Test Systems.

In other words, they’ve already blown past their own raised guidance, and they’re not done yet. Erickson added, "We also have significant additional customer demand forecasted over the next few months across multiple markets…and we expect a portion of this demand to convert into bookings before the end of this fiscal year." So, the $92 million might just be the floor.

The Quarterly Numbers: A Mixed Bag With a Silver Lining

Now, let’s talk about the quarterly results that came out alongside this news. On the surface, it’s a bit of a mixed picture. Aehr reported a third-quarter adjusted loss of 5 cents per share, which actually beat the consensus estimate for a loss of 7 cents. So, they lost less money than Wall Street thought they would—that’s a win.

Sales, however, came in at $10.31 million, which was slightly below the Wall Street estimate of $10.85 million. Not a disaster, but not a beat either.

The real story, though, isn’t in the past quarter’s revenue; it’s in the future orders. The company reported quarterly bookings of $37.2 million. For a company that just did $10.31 million in sales, booking over $37 million in new business is huge. That gives them a book-to-bill ratio of over 3.5x, which is a fancy way of saying they’re taking in orders more than three times faster than they’re shipping product. That’s a screaming signal of strong customer demand, and it was driven by both wafer-level and package-level burn-in applications.

This isn’t a one-off surge, either. Back in March, Aehr snagged a new silicon photonics customer, which is another area tied to the AI-driven expansion of data centers. They received an initial order from a global networking customer for multiple test-and-burn-in systems to support silicon photonics transceivers. The demand pipeline appears to be filling up from multiple angles.

As of Thursday’s premarket session, Aehr Test Systems shares were up 14.98% at $84.19. When a stock moves that much on news, it’s usually because investors see more than just a single order; they see a company positioning itself right in the sweet spot of a booming market. And with bookings already running well ahead of plan, it seems they might be right.